Welcome to Neumomed

An ongoing revolution in therapeutic care to improve the lives of millions of patients with respiratory diseases.

The Healthcare System Problem

 
 

Slide Respiratory Diseases

Healthcare systems are struggling to meet the demand for chronic disease management due to specialist shortages and inefficient care models.

Solutions for Insurers and Healthcare Providers

We are transforming therapeutic care to enhance the well-being of millions affected by respiratory diseases.
Our solution boosts healthcare capacity with specialized programs and treatments, focusing on pivotal issues like respiratory disorders, sleep apnea therapy (TMO), smoking and vaping cessation, and promoting healthy sleep.
 
Respiratory Program Icon

Respiratory Program

Empowering healthcare providers and insurers to effectively manage and treat chronic respiratory conditions like asthma and COPD through specialized, evidence-based therapeutic programs.
Explore Click to Explore
OMT Icon

Sleep Apnea

Providing healthcare providers and insurers with effective solutions for managing sleep apnea through Orofacial Myofunctional Therapy (OMT), enhancing airway function and improving patient outcomes.

Explore Click to Explore
Smoking Cessation Program Icon

Smoking and Vaping Cessation Program

Delivering solutions for healthcare providers and insurers to guide patients in quitting smoking and vaping through personalized behavioral and medical interventions, ensuring long-term success.
Explore Click to Explore
Sleep Therapy Icon

Healthy Sleep Therapy

Partnering with healthcare providers and insurers to improve sleep health through tailored programs that address insomnia and sleep disorders, leading to better patient outcomes and reduced healthcare costs.

Explore Click to Explore

Our therapeutic model integrates three key elements across all therapies and programs, ensuring a comprehensive approach that enhances patient outcomes. These components—scientific expertise, technology, and dedicated support—work together to provide consistent and effective care:

Scientific Team Icon

Scientific Team

A team of highly skilled medical professionals and researchers develops and refines our therapies, ensuring they are grounded in the latest scientific evidence and best practices.
STM Icon

Technological Platform

The STM platform leverages AI to personalize patient care, automating processes, tracking real-time data, and providing tailored interventions. This technology supports healthcare providers in managing larger populations while enhancing patient engagement and treatment efficacy.

Neumomed Icon

Help Desk Support

We offer 24/7 help desk support to ensure seamless interaction with the STM platform. Patients receive AI-powered guidance, while healthcare providers benefit from real-time assistance, ensuring smooth operations and continuous care delivery.
Discover Our Therapeutic Model Click to Discover Our Therapeutic Model

Why Neumomed Corp?

At Neumomed Corp, we are changing the way healthcare systems approach chronic conditions by leveraging our innovative STM platform. Our solution addresses the gaps in capacity, reach, and patient adherence, allowing healthcare providers to:

Scale capacity

Through our AI-powered platform, healthcare teams can manage a larger population of patients without increasing staff or infrastructure.

Extend reach

The digital nature of our therapeutic model means that patients in remote areas or underserved communities can access high-quality care without the need for in-person visits.

Improve adherence

Our therapeutic model incorporates Cognitive Behavioral Therapy (CBT), mindfulness, and other behavioral techniques that significantly improve treatment adherence, reducing hospitalizations and improving quality of life.

Proven Impact

With 14 years of experience, our Therapeutic Model has already demonstrated measurable results. To date, Neumomed Corp has served over 30,000 patients in Colombia, generating $2 million last year in revenue. We’ve partnered with leading healthcare institutions to provide solutions that not only improve patient care but also reduce operational costs for providers.
 
 

A Scalable Solution

As we look to expand to new markets, including Peru, Mexico, and South Florida, Neumomed Corp is seeking $2 million in funding for the first phase of our expansion. These resources will enable us to scale our proven solution, helping healthcare systems in emerging markets deliver high-quality care to larger populations at a lower cost.

By investing in Neumomed Corp, you are supporting a proven, scalable solution that addresses critical gaps in healthcare, improving outcomes for both patients and providers.

Progress and Impact

 

Over 40,000 Patients Served

To date, our therapeutic programs have successfully reached and improved the health outcomes of more than 40,000 patients across various chronic conditions, including respiratory diseases, sleep disorders, and nicotine addiction. This growing number demonstrates our scalable capacity and positive track record with insurers and healthcare providers.

Strategic Partnerships Driving Population Health

Through our partnerships with major insurers and healthcare providers, Neumomed is uniquely positioned to serve large patient populations efficiently. By leveraging these collaborations, our clients can extend their healthcare services to wider audiences while optimizing costs and improving patient outcomes. These alliances empower providers to focus on holistic care, resulting in significant cost savings.

Proven Cost Reductions

 Our programs have shown a substantial reduction in healthcare costs—up to 60% for high-cost respiratory patients and 40% in sleep therapy cases. These savings come from optimized resource utilization, reduced hospitalizations, and improved adherence to treatment plans, directly benefiting both our clients and their patient populations.

High Patient Adherence and Health Outcomes

By integrating behavioral support, personalized therapies, and AI-powered monitoring, we achieve higher-than-average patient adherence rates. For example, our smoking cessation program boasts an 80% success rate, driving long-term health improvements.

Why Neumomed?

 

At Neumomed, we are changing the way healthcare systems approach chronic conditions by leveraging our innovative STM platform. Our solution addresses the gaps in capacity, reach, and patient adherence, allowing healthcare providers to:

Scale capacity

Through our AI-powered platform, healthcare teams can manage a larger population of patients without increasing staff or infrastructure.

Extend reach

The digital nature of our therapeutic model means that patients in remote areas or underserved communities can access high-quality care without the need for in-person visits.

Improve adherence

Our therapeutic model incorporates Cognitive Behavioral Therapy (CBT), mindfulness, and other behavioral techniques that significantly improve treatment adherence, reducing hospitalizations and improving quality of life.
Contact Us Click to Contact Us

Why Invest in NeumoMed Corp?

At NeumoMed Corp, we have a proven track record of success and the potential for substantial growth, making us an attractive investment opportunity in the healthcare technology sector. Here’s why investing in our company stands out:

Proven Model Generating Significant Revenue

  • Our therapeutic model is already operational and generating $2 million in revenue over the past year in Colombia alone, with partnerships established with leading health insurers.

A Scalable Solution to Global Health Challenges

  • With a unique focus on addressing respiratory diseases, sleep disorders, smoking cessation, and vaping addiction, our therapeutic approach has demonstrated its ability to scale across multiple countries and healthcare systems.
  • Next Steps: Expansion to Key Markets
    We are actively preparing to expand our solution into Peru, Mexico, and South Florida, tapping into markets where healthcare providers are struggling to manage patient care efficiently due to capacity constraints.

Significant Barriers to Entry in a Growing Market

  • Healthcare providers and insurers face high entry barriers due to a lack of specialized professionals and technological solutions that can seamlessly integrate into existing healthcare systems.
  • Our Therapeutic Model solves these challenges by improving patient adherence, expanding capacity, and reducing operational costs, making NeumoMed an essential partner for healthcare systems looking to innovate.

Cutting-Edge AI Integration

  • NeumoMed’s proprietary Smart Therapy Management (STM) platform leverages the latest advances in AI, enhancing patient care through better communication, adherence tracking, and personalized treatment protocols, ensuring scalable and efficient healthcare delivery.

A Long-Term Impact on Healthcare Systems

  • We’re not just focused on short-term gains. Our therapeutic model is designed to reduce healthcare costs, minimize hospitalizations, and improve long-term patient outcomes. These measurable benefits are a win-win for both patients and healthcare providers.

Join Us for the Next Growth Phase

  • By joining NeumoMed Corp, you’re investing in a company that’s already making a tangible difference in people’s lives and has the infrastructure in place to scale globally. We are seeking $2 million in convertible debt to fuel our expansion into new markets and further develop our world-class solutions.

Market Opportunity: Unlocking a Global Healthcare Revolution

The global healthcare industry is at a turning point. Respiratory diseases, sleep disorders, and the rising demand for smoking cessation programs represent some of the most urgent health challenges worldwide. Currently, over 1.5 billion people are affected by these conditions, putting enormous pressure on healthcare systems that lack the capacity to manage this growing demand.

NeumoMed Corp is addressing this gap with an AI-driven therapeutic model that enhances the capacity of insurers and healthcare providers to deliver high-quality care at scale. Our solution is already making a significant impact in Colombia, where we’ve partnered with the top health insurer and treated over 30,000 patients with respiratory and sleep disorders, as well as smoking cessation.

  • 1.5 billion people globally are smokers or vapers

    creating a critical demand for cessation therapies.

  • COPD and Asthma affect over 670 million people

    creating long-term opportunities for healthcare providers to improve outcomes and reduce hospitalizations.

  • Sleep disorders impact nearly 4 billion people

    and current solutions are limited in reach and effectiveness.

With NeumoMed's integrated Therapeutic Model, we empower healthcare systems to scale their services, reaching more patients and delivering cost-effective care that improves patient outcomes.

Financial Projections: Scaling a Proven Model

Our proven business model is subscription-based, generating recurring monthly revenue through partnerships with healthcare providers and insurers. In 2023, NeumoMed generated over $2 million in revenue in Colombia alone, with significant potential to expand into new markets.

As we project our future growth, we are focused on scaling our model to new regions, including Peru, Mexico, and South Florida. With these expansions, we expect to:

  • Increase our patient base to 9.000 over the next two years.
  • Achieve annual revenues exceeding $2.5 million in two years.
  • Secure new partnerships with major insurers and healthcare providers in emerging markets.

NeumoMed is seeking $2 million in funding to execute this first phase of expansion. These resources will be directed towards:

  1. Technology Development: Enhancing our AI-powered platform and scaling it for global use.
  2. Operational Expansion: Building teams in Peru, Mexico, and Florida to oversee local operations.
  3. Strategic Partnerships: Establishing new relationships with key healthcare stakeholders to ensure rapid adoption of our solution.

A Growing, High-Potential Market

  • Global Respiratory Market projected to reach $43 billion by 2026.
  • Smoking Cessation Market valued at $64 billion by 2027.
  • The growing demand for sleep disorder treatments represents a significant untapped market with long-term potential.

NeumoMed is at the forefront of this healthcare revolution, offering a scalable, effective solution that addresses both capacity and adherence challenges faced by current healthcare systems.

Technology and Innovation

At NeumoMed Corp, innovation is at the heart of everything we do. Our Smart Therapy Management (STM) platform integrates cutting-edge technology with medical expertise to address the global health challenges of respiratory diseases, smoking cessation, and sleep disorders. Here's how our Therapeutic Model stands out:

Our story

Generative AI for Patient Care

STM leverages AI to optimize the management of large patient populations. By automating routine tasks and enhancing patient interaction through natural language processing, doctors can focus on personalized care for each patient, improving treatment adherence and outcomes.

Multimodal Therapeutic Approach

Our model combines Cognitive Behavioral Therapy (CBT), mindfulness techniques, and Tiny Habits to create tailored programs for each patient, increasing the likelihood of successful therapy and long-term health improvements.

placeholder_200x200
placeholder_200x200

Seamless Integration with Healthcare Providers

The STM platform is designed to complement the existing healthcare infrastructure. It integrates with the systems of insurers and healthcare providers to maximize their capacity to deliver effective care to a larger population.

Scalable Across Markets

Our Therapeutic Model flexibility allows it to be adapted across different countries and healthcare systems, making it an ideal solution for emerging markets where healthcare resources are limited.

placeholder_200x200

Our team

At NeumoMed Corp, we are led by a dynamic and experienced team that combines expertise in medicine, technology, and business to revolutionize therapeutic care on a global scale.

Claudia Díaz

Dr. Claudia Díaz, MD

Chief Medical Officer and Co-Founder

Dr. Claudia Díaz is a specialist in Internal Medicine and Pulmonology, and the Vice President of the Colombian Society of Pulmonology and Thoracic Surgery. She has over 15 years of experience in respiratory health and sleep disorders and is instrumental in driving innovation in NeumoMed's therapeutic programs. Her leadership in medical research and treatment protocols ensures that NeumoMed’s solutions meet the highest medical standards.

Juan Carlos Salas

Juan Carlos Salas

CEO and Co-Founder

Juan Carlos Salas, an expert in engineering and business development, holds a degree in Electronic and Telecommunications Engineering, along with an MBA focused on sustainability. With extensive experience in the integration of AI-driven solutions, Juan Carlos leads NeumoMed Corp’s strategic vision and has played a critical role in developing the Smart Therapy Management (STM) platform. His leadership ensures seamless integration of technology and healthcare.

Juan Carlos Junca

Juan Carlos Junca

Chief Growth Officer

With a robust background in entrepreneurship, management consulting, and strategic partnerships, Juan Carlos Junca drives NeumoMed’s expansion efforts across new regions. His expertise lies in business development and his ability to create strategic alliances that propel the company into new markets like Peru, Mexico, and South Florida.

Tito-2

Tito Yepes

Chief Financial Officer

Tito Yepes brings a wealth of experience in economic analysis, financial modeling, and investment strategies. With a solid foundation in finance and economics, Tito ensures that NeumoMed’s financial health is aligned with its growth objectives. His stewardship in resource allocation, investor relations, and financial planning supports the company's long-term sustainability.

Felipe Salazar

Felipe Salazar

Director of Business Expansion

Felipe Salazar is an expert in retail management and wholesale distribution, with a strong track record of leading companies to operational excellence. His MBA in Business Administration and experience in scaling businesses equip him to lead NeumoMed's efforts in growing its global footprint, particularly in Latin America and the U.S.

Investor Opportunity

As we continue to revolutionize therapeutic care, NeumoMed Corp offers a unique investment opportunity in a rapidly growing global health sector. The rise of respiratory diseases, sleep disorders, and addictions like smoking and vaping have created an urgent need for scalable, effective solutions that reduce healthcare costs and improve patient outcomes. Our advanced STM platform and integrated therapeutic models are already proving effective, with significant traction in Colombia and plans for expansion into Peru, Mexico, and the U.S.

Why Invest in NeumoMed Corp?

Proven Success

Our innovative solutions have already generated $2 million in revenue within the past year, and we have successfully treated more than 30,000 patients with our therapies and programs.

Scalable Model

With a Therapeutic Model designed for global reach, we are poised for significant expansion, starting with Latin America and the U.S.

Strong Partnerships

We have established partnerships with key healthcare providers and insurance companies, ensuring a broad market entry.

High-Impact Market

In our first phase of expansion, we project revenues exceeding USD 2.5 million by 2026. Following this, we will initiate our second phase of growth, leveraging our established success to continue expanding into new markets and scaling our solution.

By investing in NeumoMed Corp, you will join us in shaping the future of therapeutic healthcare, leveraging advanced technology to improve lives on a global scale.

 

 

About

Get to know us

Our story

Our Company

At NeumoMED, we are committed to revolutionizing therapeutic care for patients with respiratory diseases. Our mission is to enhance the quality of life for millions by delivering innovative and effective treatment solutions. Through cutting-edge research and dedicated patient care, we strive to lead the way in respiratory health. Our team of experts is passionate about making a tangible difference in the lives of those we serve. Join us on our journey to breathe new life into respiratory care.

Contact Us To Invest

Get in Touch with NeumoMED